Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene
- 1 October 1994
- journal article
- Published by Elsevier in Contraception
- Vol. 50 (4), 301-318
- https://doi.org/10.1016/0010-7824(94)90018-3
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to womenAmerican Journal of Obstetrics and Gynecology, 1990
- Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulinAmerican Journal of Obstetrics and Gynecology, 1990
- The Functions of Corticosteroid-Binding Globulin and Sex Hormone-Binding Globulin: Recent Advances*Endocrine Reviews, 1990
- Gestodene: A novel synthetic progestin — characterization of binding to receptor and serum proteinsContraception, 1989
- Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrelFertility and Sterility, 1984
- Serum non-protein bound percentage and distribution of the progestin ST-1435: no effect of ST-1435 treatment on plasma SHBG and CBG binding capacitiesActa Endocrinologica, 1983
- Distribution and percentages of non-protein bound contraceptive steroids in human serumThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDSClinical Endocrinology, 1979
- Effects of d-norgestrel induced decreases in sex hormone binding globulin capacity on the d-norgestrel levels in plasmaContraception, 1977
- SEX‐HORMONE‐BINDING GLOBULINClinical Endocrinology, 1974